Incidence and mortality from non-Hodgkin lymphoma in Europe: The end of an epidemic?
Incidence and mortality from non-Hodgkin lymphoma in Europe: The end of an epidemic?
复制标题
DOI：
10.1002/ijc.23722
复制
发表时间：
2008-10-15
影响因子：
6.4
通讯作者：
La Vecchia, Carlo
中科院分区：
文献类型：
--
作者：
Bosetti, Cristina;Levi, Fabio;La Vecchia, Carlo
非霍奇金淋巴瘤（NHL）是过去几十年来欧洲和北美发病率和死亡率不断上升的少数肿瘤之一。为了更新 NHL 的趋势，我们考虑了几个欧洲国家截至 2004 年的死亡率数据，并出于比较目的考虑了美国和日本的死亡率数据。我们还分析了提供国家数据的选定欧洲国家的发病模式。在大多数欧洲国家，NHL 死亡率在 20 世纪 90 年代中期开始上升，并在接下来的十年中开始趋于平稳或下降。然而，东欧的比率仍在上升。总体而言，在欧盟，从 1990 年代末到 2000 年代初，NHL 的男性死亡率从 4.3/100,000 下降到 4.1，女性从 2.7 下降到 2·5。同样，美国三人组的 NHL 死亡率从 6.5/100,000 下降到 5.5，美国女性的死亡率从 4.2 下降到 3.5。在大多数考虑的国家中，NHL 发病率在 1995-99 年期间有所上升，但此后往往趋于平稳或下降，北欧国家的情况尤其有利。因此，20 世纪下半叶观察到的 NHL 疫情在欧洲和世界其他发达地区现已开始趋于平稳。 (C) 2008 Wiley-Liss, Inc.
Non-Hodgkin lymphomas (NHL) are among the few neoplasms whose incidence and mortality have been rising in Europe and North America over the last few decades. To update trends from NHL, we considered mortality data up to 2004 in several European countries, and for comparative purpose in the USA and Japan. We also analyzed patterns in incidence for selected European countries providing national data. In most European countries, NHL mortality rose up to the mid 1990s, and started to level off or decline in the following decade. The rates were, however, still increasing, in eastern Europe. Overall, in the European Union, mortality from NHL declined from 4.3/100,000 to 4.1 in men and from 2.7 to 2 5 in women between the late 1990s and the early 2000s. Similarly, NHL mortality rates declined from 6.5/100,000 to 5.5 in US trien and from 4.2 to 3.5 in US women. In most countries considered, NHL incidence rates rose up to 1995-99, while they tended to level off or decline thereafter, with particular favorable patterns in countries from northern Europe. Thus, the epidemic of NHL observed during the second half of the 20th century has now started to level off in Europe as in other developed areas of the world. (C) 2008 Wiley-Liss, Inc.